Main Article Content
The main objective of this study is to show how both hepatitis B and C Viral Infection in B-Thalassemic patients occurs and a study of their liver functions. To define the occurrence of either hepatitis A or B and C viral infection across the B-Thalassemia key clients/patients in Thalassemia Center of AL-Diwanyia Maternity and Children hospital from 1st. Jan. – 1st.Nov.2017. To carry out the study, it enlisted 54 patients; 31 patients were male (57.4%) in which the male to the female ratio was 01.4:01. Results for this study revealed that 2 patients had Hepatitis B (3.7%), and 6 patients had Hepatitis C (11.1%). The Liver enzymes were significantly more in those patients having either Hepatitis B or C viral infection. According to this study, it was revealed that the occurrence of HBsAg seropositive in B-thalassemic patients was 307%, and Anti-HCV seropositive were 11.1%, and the rate is lower than reported in many countries. The occurrence of Anti-HCV seropositive is higher than that for HBsAg seropositive. Also, the probability of having liver injury was high for thalassemic patients whom were HBsAg positive & Anti-HCV positive than that of seronegative for HBsAg & Anti- HCV.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.